Emphasis on Type (Original Drug and Generic Drug); End-User (Hospitals, Clinics, and Others); and Region/Country
The prostaglandin market was valued at 450 Mn and is expected to grow at a strong CAGR of around 6% during the forecast period (2022-2030). Prostaglandins are hormone-like substances that are involved in many physiological processes in the body, including inflammation, pain, and blood clotting. They are used in a variety of medical applications, including the treatment of glaucoma, erectile dysfunction, and certain gastrointestinal disorders. The growth of the market for prostaglandin is mainly driven by the increasing demand for the effective treatment of disease with minimal side effects. Further, increasing production facilities by the major market players also attributes to the growth of the prostaglandin market. For instance, in January 2023, Sanofi started its prostaglandin production in Budapest, Hungary. The drug ingredient is mainly used for ophthalmology products and forms a hallmark of glaucoma treatment.
Some of the major players operating in the market include Sanofi.; Cayman Chemical; YONSUNG Fine Chemicals Co.; Johnson Matthey; Chirogate International Inc.; Everlight Chemical Industrial Co.; Merck KGaA; Zhejiang Ausun Pharmaceutical Co., Ltd.; AspenBio; and Pfizer Inc Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst type, the natural segment is expected to grow at a higher CAGR during the forecast period.”
Based on type, the market is segmented into synthetic and natural. As per our analysis, the natural segment is expected to grow at a higher CAGR during the forecast period. Natural prostaglandins are natural or dietary supplements that contain prostaglandins such as herbs, fish liver, and others. The increasing demand for natural and organic medicines is the main reason for the fast growth of the natural prostaglandin segment.
“Amongst category, the human segment held the dominant share in 2021.”
Based on the category, the market is segmented into human and veterinary. As per our analysis, the human segment held the dominant share in 2021. The rising prevalence of chronic diseases, along with the rapidly rising population of humans globally is the major reason for the dominant share of the human prostaglandin segment in the market. Furthermore, the increasing prevalence of inflammation among human population is also an attributing factor for the domination of the segment.
“Amongst application, the natural segment is expected to grow at a higher CAGR during the forecast period.”
Based on application, the market is segmented into cardiovascular, gynecological and obstetrical, ophthalmologic, and others. As per our analysis, the gynecological and obstetrical segment is expected to grow at a higher CAGR during the forecast period. Prostaglandins have multiple effects on female reproductive system as it helps in uterine contraction during pregnancy, helps in the regulation menstrual cycle, and in the preparation of cervix during the childbirth. The rising awareness about maternal health, along with the increasing childbirth are the important factors catalyzing the growth of the segment.
Prostaglandin Market Report Coverage
“Asia Pacific is expected to grow with the highest CAGR Prostaglandin market during the forecast period.”
Asia Pacific is expected to grow with the highest CAGR prostaglandin market during the forecast period due to its large population and the orthopedic diseases in the region are major attributing factors for the market growth of the prostaglandin market in the region. For instance, as per the International Osteoporosis Foundation, around 13 million people in Japan suffer from osteoporosis. Bone diseases cause painful and disabling fragility fractures, often resulting in long-term loss of mobility and independence in older people.
Reasons to buy this report:
Customization Options:
The global prostaglandin market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1. Market Introduction
2. Research Methodology Or Assumption
3. Market Synopsis
4. Executive Summary
5. Global Prostaglandin Market Covid-19 Impact
6. Global Prostaglandin Market Revenue, 2020-2028f
7. Market Insights By Type
8. Market Insights By Category
9. Market Insights By Application
10. Market Insights By Region
11. Prostaglandin Market Dynamics
12. Prostaglandin Market Opportunities
13. Prostaglandin Market Trends
14. Demand And Supply-side Analysis
15. Value Chain Analysis
16. Pricing Analysis
17. Strategic Insights
18. Competitive Scenario
19. Company Profiled
20. Disclaimer
Research Methodology for the Prostaglandin Market Analysis (2022-2030)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global Prostaglandin market were the three major steps undertaken to create and analyze the adoption of prostaglandin in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of global prostaglandin market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the prostaglandin market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the prostaglandin market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as type, category, and application. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the prostaglandin market. Further, we conducted factor analysis using dependent and independent variables such as type, category, and application of the prostaglandin market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the Prostaglandin market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global Prostaglandin market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2030 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global prostaglandin market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the type, category, and application in the global prostaglandin market.
The main objective of the Global Prostaglandin Market Study
The current & future market trends of the global prostaglandin market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
